|

Allogeneic γδ T (ABOUT) cells Clinical Trials

1 actively recruiting trial

Also known as: ARIH1 and BCL11b knockout γδ T cells, ARIH1KO/BCL11bKO γδ T cells

Top Sponsors

  • Peking University Third Hospital1

Indications

  • Glioblastoma Multiforme (GBM)1
  • Glioblastoma (GBM)1
  • Cancer1

Other1 trial

Allogeneic γδT Cells in Glioblastoma
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.